Roche buys precision medicine firm Ignyta for $1.7B
(By Anuja Vaidya for Becker’s Hospital Review) Roche, a global pharmaceuticals and diagnostics company, is acquiring Ignyta for $27 per share in
Read More(By Anuja Vaidya for Becker’s Hospital Review) Roche, a global pharmaceuticals and diagnostics company, is acquiring Ignyta for $27 per share in
Read More(By Brian Zimmerman for Becker’s Hospital Review) When CMS updated the methodology used in its Overall Hospital Quality Star Rating
Read MoreIn a new study, researchers looked at 22 million deaths nationwide and found older adults are more likely to die
Read MorePatients who get spinal surgery known as anterior cervical discectomy and fusion (ACDF), at outpatient centers may be more likely
Read More(By Molly Gamble for Becker’s Hospital Review) Nearly one-third of Americans believe President Donald Trump has repealed the ACA, or
Read More(By Molly Gamble for Becker’s Hospital Review) Ten of the largest technology companies in the United States were involved in
Read More(By Brian Zimmerman for Becker’s Hospital Review) Nurses are the most trusted professionals in the United States, according to the
Read MoreA new study in The New England Journal of Medicine confirms earlier work suggesting that MRI scans are safe for
Read More(By Brian Zimmerman for Becker’s Hospital Review) Cook County and five other counties encompassing Chicago suburbs recently filed lawsuits against
Read More(By Rebecca Robbins for STAT) These are boom times for the multibillion-dollar drug advertising industry — and the parade of
Read More